02:39 PM, 2nd Feb 2026
Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve 1. To consider and approve Unaudited Standalone and Consolidated Financial Results of the Company along with the Limited Review Report for the quarter ended 31st December 2025; 2. To consider any other business Matter with the permission of a Chairman.